Executive Summary The Global Human Nutrition Market was valued at USD 252.38 Billion in the year 2020. The major factors driving the growth of the global Human Nutrition market are growing demand for safe and nutritious health products and supplements, rising disposable income and increasing concern over health among consumers.
Based on Application, the market is segmented into Dietary Supplement, Functional Nutrient, Infant Nutrition and Food and Beverages. The Dietary Supplement segment is expected to grow at a higher CAGR during the forecast period primarily because the elderly population is focusing on adapting to nutritional supplements specifically tailored to their needs to maintain their good health and quality of life. The process of ageing results in various changes in an individual, including psychological, physiological, and social, which affects their dietary and food choices.
North America is expected to hold the largest market share in the Global Human Nutrition market in 2026. This can be attributed to the United States being the epicentre for the market owing to the presence of a well-developed distribution channel along with the production hub of key manufacturers. Furthermore, the increasing demand for such dietary supplements across countries like Mexico is the factor contributing to the growth of the market in North America.
Factors such as the growing prevalence of various diseases due to unhealthy eating, rising demand for fortified food products, rising disposable income, and growing health consciousness and demand for nutritional supplements are driving the growth of the global Human Nutrition Market. Moreover, a surging preference for fortifying and nutritional food additives is one of the major factors fostering the growth of the human nutrition market.
Scope of the Report • The report presents the analysis of the Human Nutrition market for the historical period of 2016-2020 and the forecast period of 2021-2026.
• The report analyses the Human Nutrition Market by Value (USD Million).
• The report analyses the Human Nutrition Market by Product Type (Vitamins, Probiotics, Proteins/Amino Acids, Minerals/ Others).
• The report analyses the Human Nutrition Market by Application (Dietary Supplement, Functional Nutrient, Infant Nutrition, Food & Beverages).
• The report analyses the Human Nutrition Market by Distribution Channel (OTC, Prescribed).
• The Global Human Nutrition Market has been analysed by countries (United States, Canada, United Kingdom, Italy, France, Germany, China, Japan, India, Australia).
• The key insights of the report have been presented through the frameworks of SWOT and Porter’s Five Forces Analysis. Also, the attractiveness of the market has been presented by region, by Product Type, Application and Distribution Channel.
• Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include ADM Company, Glanbia PLC, Nestle, Kerry Group PLC, DSM Company, Bayer Group, Abbott Laboratories, Usana Health Sciences, Corbion NV, Amway.
Key Target Audience
• Human Nutrition Industry Vendors
• Nutrition Companies
• Consulting and Advisory Firms
• Government and Policy Makers
• Regulatory Authorities
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Healthcare Disinfectants and Sanitizers Market Report The healthcare disinfectants and sanitizers market by revenue is expected to grow at a CAGR of 10.89% during the period 2022–2027. In 2021, disinfectants accounted for the major share...
The corporate wellness market is projected to register a CAGR of 5.92% during the forecast period, with a revenue of approximately USD 52,703.51 million in 2020. It is expected to reach USD 72,728.72 million by 2026. Due to the impact of COVID-19, it was found that people with chronic diseases, including diabetes, high blood pressure,...
Executive Summary The Global Transcatheter Tricuspid Valve Intervention (TTVI) market is projected to display noteworthy growth and estimated to reach value of USD 10.17 billion by the year 2030 with Europe region leading the regional market share. Demand for transcatheter valvular therapeutics for tricuspid valve diseases...
119 pages •
By Euromonitor International
• Oct 2021
The lack of structured and organised measures to avoid the rapid spread of COVID-19 throughout the country in 2020 and the beginning of 2021, as well as the slow pace of vaccination in the first half of 2021, have positioned Brazil as the country with the second highest death toll worldwide, reaching over half a million deaths. Consumer...
The global epilepsy monitoring devices market is projected to reach USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7% during the forecast period. The growth in this market is driven by the increasing incidence and prevalence of epilepsy, growing preference for ambulatory healthcare and increasing use of wearables, growing...
Executive Summary According to the report, the global Idiopathic Pulmonary Fibrosis Market is projected to display robust growth valued at USD 3271.3 Million in the year 2020 with North America leading the regional market share. The primary driver of growth in the IPF market in recent years has been an increased...
The global wearable healthcare devices market is projected to reach USD 30.1 billion by 2026 from USD 16.2 billion in 2021, at a CAGR of 13.2% during the forecast period. Market growth is driven by factors such as the development of technologically advanced products and robust penetration of 3G and 4G networks for uninterrupted healthcare...
59 pages •
By Euromonitor International
• Nov 2021
? The COVID-19 pandemic continued to have a mixed impact on sales across consumer health in 2021. Many OTC categories saw higher demand as they were used to treat the symptoms of the COVID-19 virus as well as side-effects of the vaccine, while some herbal/traditional categories saw higher demand as consumers looked to improve their overall...
The lab on a chip and microarrays (biochip) market is projected to register a CAGR of 13.96% during the forecast period, with a revenue of approximately USD 13,360.69 million in 2020 and is expected to reach 28,831.7 million by 2026. With the outbreak of COVID–19, the market is expected to have a net positive impact on the lab-on-a-chip...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Healthcare Claims Management Market Report The healthcare claims management market by revenue is expected to grow at a CAGR of 4.79% during the period 2022–2027. THE HEALTHCARE CLAIMS MANAGEMENT MARKET INSIGHTS • Artificial...
Health Insurance Coverage
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.